Disc Medicine Initiates Phase 1b/2 Clinical Study of DISC-0974 in Myelofibrosis Patients with Severe Anemia
Open-label study will evaluate the potential for DISC-0974, a first-in-class, anti-HJV (hemojuvelin) monoclonal antibody to improve anemia in myel...
United States United Kingdom Srdan Verstovsek John Quisel University Of Texas Md Anderson Cancer Center Chief Executive Officer
Source: businessinsider.com